Company intelligence / Profile preview
Disc Medicine
Cambridge, Massachusetts, United Statesdiscmedicine.com ↗
- Ownership
- Public · IRON
- Employees
- ~84
- Development stage
- Other
01
Overview
Disc Medicine has reported positive early clinical results. For example:
- Therapeutic areas
- HematologyRare DiseasesNephrology
- Modalities
- Small molecules (e.g., Bitopertin)Monoclonal antibodies (mAbs; e.g., DISC-0974, DISC-3405)
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
03
Partnerships
AbbVie – exclusive global license for DISC‑0974Mabwell Therapeutics – licensed DISC‑3405
04
Financials
- Market cap
- $3B
- Total revenue
- $0
- Enterprise value
- $2.4B
Beyond the preview
Go deeper on Disc Medicine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Disc Medicine.